Green Cross Holdings Corporation is a holding company, which operates pharmaceutical, biotechnology, distribution system, life insurance, and healthcare entities.  The Company also invests in biotechnology venture capital and markets medical research information.

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ì­ìíë©ì¤2ì°)

Decision on Transfer of Shares or Investment Certificates of Other Corporations

South Korea

BIONEER Corp. provides molecular biology products & services.  The Company's product includes oligo synthesis, nucleic acid amplication and purification kits, and instruments for detecting biowarfare agents.

Seegene, Inc. manufactures In Vitro Diagnostic (IVD) products mainly through molecular diagnostic method.  The Company provides diagnostic & screening products for cancer, sepsis, influenza and virus infection.

SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.

Eubiologics Co. Ltd. researches and develops biopharmaceuticals. The Company offers bacterial vaccines for new epidemics and antibiotic resistance. Eubiologics operates in South Korea.

Genexine Co., Ltd. is bio technology company. The Company specialize in the development of therapeutic vaccines and next generation antibody fusion protein medications.

Pharmicell Co.,Ltd. is a Biotechnology company.  The Company's business area inlcudes stem cell therapeutics, Stem cell banking, Bio-based business and Cosmetics.

Amicogen, Inc. develops, produces and markets specialty enzymes and functional food ingredients. The Company offers special biocatalysts,  enzyme-based new functional materials, health foods, and consumer products.

ISU ABXIS Co., Ltd. develops therapeutic antibodies for such as antithrombus, anti-inflammatory, anti-cancer, and rare diseases.  The Company also provides medical service such as anti-cancer drug sensitivity examination and gene examination.

iNtRON Biotechnology, Inc. is a bio-venture developing bio-active agents targeting infectious organisms and driving its commercial use.

NIBEC Co Ltd. manufactures, researches, and develops medical and dental products.  The Company's products include a Bulyonghwa treatment of residual protein and teeth whitening products.

Heron Therapeutics, Inc. operates as a biotechnology company. The Company offers proprietary biochronomer drug delivery technology which is designed to improve the therapeutic profile of injectable pharmaceuticals, as well as focuses on identifying current therapies with the potential to be reformulated.

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company. The Company develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Emergent also develops and commercializes therapeutics and other specialty products for hospitals and clinics.

SunMax Biotechnology Co Ltd. is a medical device company dedicated to the development, manufacturing and commercialization of bio-surgical products. The Company specializes in the production of medical grade porcine collagen that is used in medical applications and biochemistry research.

Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products.  The Company's products generate and enhance immune system responses to treat cancer.  The DCVax product candidate platform creates cancer immunotherapies.

Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.

Basilea Pharmaceutica AG operates as a biopharmaceutical company. The Company focuses on the research, development, and commercialization of products targeting the medical challenge of resistance and non-response to current treatment options for fungal infections, bacterial infections, and cancer.

Sinovac Biotech Ltd. researches, develops, manufactures, and markets various vaccines, including flu 
vaccines and vaccines for Hepatitis A.  The Company's products are sold in the Peoples Republic 
of China and other countries.

Oxford Biomedica is a gene and cell therapy group focused on developing treatments for serious diseases based around its FDA approved lentiviral vector delivery platform. The Company leverages this platform to develop in vivo and ex vivo products in-house and with global Pharmaceutical and Biotech partners and has created it's own portfolio of gene and cell therapy product candidates.

Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.

Ningbo Medical System Biotechnology Co., Ltd. manufactures biochemistry reagent and analyzers. The Company specializes in clinical laboratory service, scientific research, development and other related services.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Green Cross Holdings (005250 KS)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)

Decision on Transfer of Shares or Investment Certificates of Other Corporations

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ì­ìíë©ì¤2ì°)

Decision on Transfer of Shares or Investment Certificates of Other Corporations

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ì­ìíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ì­ìíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ì­ìíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)

Extension of designation as Temporary Overheated Issue(Disparity ratio, 3 day- Periodic Call Auction Trading)(ë ¹ììíë©ì¤2ì°)